阿托伐他汀对ApoE-/-小鼠主动脉粥样硬化和钙化的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

南京市卫生局重点项目(ZKX10016)


Modulation of Atherosclerosis and Calcification of ApoE-/- Mice by Atorvastatin
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨阿托伐他汀对ApoE-/-小鼠主动脉粥样硬化及钙化的影响。方法 12只6周龄ApoE-/-小鼠,予以高脂饮食喂养8周后,随机分为高脂组(n6)和高脂加阿托伐他汀组(n6),连续灌胃干预8周,于22周龄时处死,测定血清血脂、IL-6及A-SAA水平;HE染色观察主动脉粥样硬化及Von Kossa染色观察主动脉钙化;免疫组织化学染色法分析比较两组VCAM-1、MCP-1、BMP-2表达;阿托伐他汀干预人主动脉内皮细胞,测定细胞内钙含量及AKP活力,并用Western blot法测定BMP-2蛋白表达水平。结果 高脂加阿托伐他汀组ApoE-/-小鼠血清TG、TC及LDLC水平显著低于高脂组(P<0.05);且血清IL-6及A-SAA水平较高脂组亦显著降低 (P<0.05);高脂组ApoE-/-小鼠主动脉内膜出现典型粥样硬化斑块,管腔面积缩小,高脂加阿托伐他汀组的病变程度较轻;但高脂加阿托伐他汀组ApoE-/-小鼠主动脉内膜钙盐沉积量显著高于高脂组(P<0.05)。高脂加阿托伐他汀组ApoE-/-小鼠主动脉血管壁VCAM-1、MCP-1的表达显著低于高脂组(P<0.01),而BMP-2的表达显著高于高脂组(P<0.01)。阿托伐他汀处理人主动脉内皮细胞后,高剂量阿托伐他汀可使细胞内BMP-2蛋白表达水平显著高于对照组(P<0.05),并使钙含量及AKP活力比低剂量组和对照组显著增加(P<0.01,P<0.05)。 结论 阿托伐他汀可降低高脂喂养的ApoE-/-小鼠血清TG、TC、LDL-C及IL-6、A-SAA水平,减少主动脉血管壁VCAM-1、MCP-1的表达,同时减轻主动脉粥样硬化的病变程度;但增加ApoE-/-小鼠主动脉内膜BMP-2表达,促进钙盐沉积,增加人主动脉内皮细胞BMP-2蛋白表达、钙含量及碱性磷酸酶活力,加重主动脉内膜的钙化。

    Abstract:

    Aim To assess the effect of atorvastatin on ApoE-/- mice atherosclerosis and calcification. Methods Six week old male ApoE-/-mice were fed with diets containing 45% kcal from fat . The mice received diets ad lib for 8 weeks and had free access to water. Then the mice were randomly divided into two groups: atorvastatin group(n6) or high fat group (n6). After 8 weeks of diet, mice were killed,blood was collected and plasma TG,TC,HDL-C,LDL-C,IL-6 and A-SAA concentrations were measured. Aotic sections were stained with hematoxylin and eosin or von kossa and observed under microscope. Immunohistochemical staining was performed to visualize the expresssions of vascular MCP-1,VCAM-1and BMP-2. Human Aorta Endothelial Cells(HAEC) were treated with different doses of atorvastatin. The level of BMP-2,calcium content and AKP activity were measured. Results Serum levels of TG,TC,LDLC,IL-6 and A-SAA in the atorvastatin group significantly decreasd compared with those in the high fat group(P<0.05). Atherosclerotic plaques were observed in ApoE-/- mice of the high fat group. And the plaque lesions revealed more limited in atorvastatin groups compared with those in the high fat group. However,the calcium mineral deposits on vascular tissue induced by atorvastatin were stronger than the high fat group(P<0.05). The expressions of vascular MCP-1 and VCAM-1 in atorvastatin group significantly decreased compared with those in the high fat group(P<0.01). However,the expression of BMP-2 in atorvastatin group was increased compared with the high fat group(P<0.01). Atorvastatin increased HAECs BMP-2 expression compared with the control group(P<0.05),and further increased the calcium deposition and the activity of AKP significantly compared with the control and low-dose atorvastatin group (P<0.01,P<0.05). Conclusion Atorvastatin may reduce the levels of serum TG,TC,LDLC,IL-6 and A-SAA,decrease the expressions of vascular MCP-1,VCAM-1 and inhibit the progression of atherosclerosis lesion in ApoE-/- mice. However, Atorvastatin may increase the expression of BMP-2 and accelerate calcium deposition, stimulate the HAEC calcification and the activity of AKP, thus affect calcification of aortic tunica intima.

    参考文献
    相似文献
    引证文献
引用本文

仲英洁,张子为,徐 郁,花晓敏,胡 云.阿托伐他汀对ApoE-/-小鼠主动脉粥样硬化和钙化的影响[J].中国动脉硬化杂志,2013,21(04):305~310.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2012-05-25
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: